Literature DB >> 11440436

Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system.

F G Barker1, S Amin-Hanjani, W E Butler, S Lyons, R G Ojemann, P H Chapman, C S Ogilvy.   

Abstract

OBJECTIVE: Hemorrhages from cerebral cavernous malformations (CMs) sometimes seem to occur in closely spaced "clusters" interspersed with long hemorrhage-free intervals. Clustering of hemorrhages could affect retrospective assessments of radiosurgery efficacy in prevention of CM rehemorrhage. However, this empirical observation had not been tested quantitatively. To test whether CM hemorrhages tend to cluster, we reviewed pretreatment rebleeding rates after a first symptomatic hemorrhage in CM patients who later underwent surgery or radiosurgery.
METHODS: We performed a retrospective review of 141 patients with CMs who presented with clinically overt hemorrhage, and who subsequently underwent surgery or proton beam radiosurgery during an 18-year period. Statistical models were used to analyze all events per person and identify potential variation in rebleeding risk with time after a previous hemorrhage.
RESULTS: Sixty-three of 141 patients experienced a second hemorrhage before treatment; 16 had additional hemorrhages. Five hundred thirty-eight patient years elapsed between first hemorrhages and treatment. The cumulative incidence of a second hemorrhage after the first CM hemorrhage was 14% after 1 year and 56% after 5 years. During the first 2.5 years after a hemorrhage, the monthly rehemorrhage hazard was 2%. The risk then decreased spontaneously to less than 1% per month, which represents a 2.4-fold decline (P < 0.001). Rehemorrhage rates were higher in younger patients (P < 0.01), but not in females or in patients with deep lesions. Shorter intervals between successive hemorrhages did not predict higher subsequent rehemorrhage risk.
CONCLUSION: The rehemorrhage rate from untreated CMs is high initially, and it decreases 2 to 3 years after a previous hemorrhage. This hazard pattern generates the observed temporal clustering of hemorrhages from untreated CMs.

Entities:  

Mesh:

Year:  2001        PMID: 11440436     DOI: 10.1097/00006123-200107000-00002

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  23 in total

Review 1.  Management of hemorrhage from cavernous malformations.

Authors:  Sachin Batra; Karen Rigamonti; Daniele Rigamonti
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

Review 2.  Cavernous malformations: natural history, diagnosis and treatment.

Authors:  Sachin Batra; Doris Lin; Pablo F Recinos; Jun Zhang; Daniele Rigamonti
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

Review 3.  Natural history of cavernous malformation: Systematic review and meta-analysis of 25 studies.

Authors:  Shervin Taslimi; Amirhossein Modabbernia; Sepideh Amin-Hanjani; Fred G Barker; R Loch Macdonald
Journal:  Neurology       Date:  2016-04-22       Impact factor: 9.910

4.  Haemorrhage into a cavernoma after traumatic head injury in a child.

Authors:  Rosalie Ogborne; Jochem Spoor; Greg James
Journal:  Childs Nerv Syst       Date:  2017-05-24       Impact factor: 1.475

5.  Surgical Approaches for Symptomatic Cerebral Cavernous Malformations of the Thalamus and Brainstem.

Authors:  Dale Ding; Robert M Starke; R Webster Crowley; Kenneth C Liu
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2017-03-31

6.  Familial cerebral cavernous angiomas: clinical and genetic features in a Chinese family with a frame-shift mutation in the CCM1 gene (krit1).

Authors:  Hui Zhu; Yingjie Guo; Xuemin Feng; Rensheng Zhang; Chunkui Zhou; Guibo Li; Jingyao Liu
Journal:  J Mol Neurosci       Date:  2014-09-04       Impact factor: 3.444

7.  Diagnosis and treatment of vascular malformations of the brain.

Authors:  Bradley A Gross; Rose Du
Journal:  Curr Treat Options Neurol       Date:  2014-01       Impact factor: 3.598

8.  Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease.

Authors:  Romuald Girard; Omaditya Khanna; Robert Shenkar; Lingjiao Zhang; Meijing Wu; Michael Jesselson; Hussein A Zeineddine; Anupriya Gangal; Maged D Fam; Christopher C Gibson; Kevin J Whitehead; Dean Y Li; James K Liao; Changbin Shi; Issam A Awad
Journal:  Biomark Med       Date:  2016-02-09       Impact factor: 2.851

9.  Clinical characteristics and surgical outcomes of solitary spinal epidural cavernous angiomas.

Authors:  Tao Yang; Fei Wang; Chaoshi Niu
Journal:  Oncol Lett       Date:  2018-02-12       Impact factor: 2.967

10.  Management of intracranial cavernous malformation in pediatric patients.

Authors:  Jae-Whan Lee; Dong-Seok Kim; Kyu-Won Shim; Jong-Hee Chang; Seung-Kon Huh; Yong-Gou Park; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2007-09-18       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.